Sterilization and preservation influence the biophysical properties of human amnion grafts

Biologicals

Volumn 36, Issue 4, 2008, Pages 248-255

  von Versen Hoeynck, Frauke ^a,c   Steinfeld, Andre Per ^a   Becker, Jakob ^a   Hermel, Martin ^a   Rath, Werner ^a   Hesselbarth, Uwe ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b DIZG German Institute for Cell and Tissue Replacement   (Germany)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Amniotic membrane; Mechanical properties; Peracetic acid; Sterilization; Wound dressing

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ALCOHOL; COLLAGEN TYPE 5; COLLAGEN TYPE 7; DOUBLE STRANDED DNA; DYE; OXYGEN; PERACETIC ACID; SULFUR;

ALLOGRAFT; AMNION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EYE SURGERY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSTRUMENT STERILIZATION; MOISTURE; PRIORITY JOURNAL; TENSILE STRENGTH; THICKNESS; TISSUE GRAFT; TISSUE PRESERVATION; VAPOR; WOUND DRESSING;

ALGORITHMS; AMNION; BIOPHYSICS; CELL MEMBRANE PERMEABILITY; FEMALE; HUMANS; OXYGEN; PREGNANCY; STERILIZATION; TENSILE STRENGTH; TISSUE PRESERVATION; TRANSPLANTS; WATER;

EID: 45849121704     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2008.02.001     Document Type: Article

References (86)

1. von Versen-Hoeynck F. Humanes Amnion-Experimentelle Untersuchungen und klinische Erfahrungen (2003), Humboldt-University, Berlin
2. Sorsby A.H., and Reed J.H. Further experience with amniotic membrane grafts in caustic burns of the eye. Br J Ophthalmol 31 (1947) 409-418
3. Gruss J.S., Dennis B.C., and Jirsch D.W. Human amniotic membrane: a versatile wound dressing. CMA J 1 18 (1978) 1237-1256
4. Ramakrishnan K.M., and Jayaraman V. Managment of partial-thickness burn wounds by amniotic membrane: a cost-effective treatment in developing countries. Burns 23 1 (1997) 33-36
5. Sabella N. Use of fetal membranes in skin grafting. Med Rec NY 83 (1913) 478
6. Sorsby A., and Symons H.M. Amniotic membrane grafts in caustic burns of the eye. Br J Ophthalmol 30 (1946) 337-345
7. Bennett J.P., Matthews R., and Faulk W.P. Treatment of chronic ulceration of the legs with human amnion. Lancet 31 (1980) 1153-1156
8. Egan T.J., O'Driscoll M.B., and Thakar D.R. Human amnion in the Management of chronic ulceration of the lower limb: A clinico-pathologic study. VASA 3 (1983) 197-203
9. Colocho G., Graham W.P., Green A.E., Matheson D.W., and Lynch D. Human amniotic membrane as a physiological wound dressing. Arch Surg 109 (1974) 370-373
10. Faulk W.P., Matthews R., Stevens P.J., Bennett J.P., Burgos H., and Hsi B.L. Human amnion as an adjunct in wound healing. Lancet 31 (1980) 1156-1158
11. Thomsen G., Stöhr C., and Löwenberg J. Anwendung von Eihaut zur Wunddeckung. Gynäkol Prax 8 (1984) 601-605
12. Kim J.S., Kim J.C., Na B.K., Jeong J.M., and Song C.Y. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 70 (2000) 329-337
13. Solomon A., Rosenblatt M., Monroy D., Ji Z., Pflugfelder S.C., and Tseng S.C. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 85 (2001) 444-449
14. Tseng S.C., Li D.Q., and Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 179 (1999) 325-335
15. Talmi Y.P., Sigler L., Inge E., Finkelstein Y., and Zohar Y. Antibacterial properties of human amniotic membranes. Placenta 11 (1991) 285-288
16. Hao Y., Ma D.H., Hwang D.G., Kim W.S., and Zhang F. Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane. Cornea 19 (2000) 348-352
17. Akle C.A., Welsh K.I., Adinolfi M., Leibowitz S., and McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 11 (1981) 1003-1005
18. Akle C.A., Adinolfi M., and McColl I. Permeability of the amniotic membrane and its potential application for transplantation purposes. Biol Res Pregnancy 2 1 (1981) 23-27
19. Trelford J.D., and Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 134 7 (1979) 833-845
20. Matthews R.N., Faulk W.P., and Bennett J.P. A review of the role of amniotic membranes in surgical practice. Obstet Gynecol Ann 11 (1982) 31-58
21. Davis J.S. Skin transplantation with review of 550 cases at Johns Hopkins Hospital. Johns Hopkins Hosp Rep 15 (1910) 307-308
22. Stern M. The grafting of preserved amniotic membranes to burned and ulcerated surfaces, substituting skin grafts. JAMA 60 (1913) 973
23. Chao Y.C., Humphrey S.S., and Penfield W.A. A new method of preventing adhesions: The use of amnioplastin in craniotomy wounds. Br Med J 1 (1940) 517-519
24. Brychta P., Adler J., Řihová H., Suchánek I., Kaloudova Y., and Koupil J. Cultured epidermal allografts strongly stimulate reepithelialisation in deep dermal burns. In: Horch R.E., Achauer B., and Munster A. (Eds). Cultured human keratinocytes and tissue-engineered skin substitutes-state of art (2001), Georg Thieme, Stuttgart
25. Brychta P., Suchánek I., Řihová H., Adler J., and Komárková J. Cultured epidermal allografts for the treatment of deep dermal burns. Acta Chir Plast 37 (1995) 20
26. Ashworth M.F., Morton K.E., Dewhurst J., Lilford R.J., and Bates R.G. Vaginoplasty using amnion. Obstet Gynecol Ann 67 (1986) 443
27. Burger K. Künstliche Scheidenbildung mittels Eihäuten. Zbl. Gynäkologie 42 (1937) 2437
28. Karjalainen O., Myllynen L., Kajanoja P., Tenhunen A., Purola E., and Timonen S. Managment of vaginal agenesis. Ann Chir Gynecol 69 (1980) 37
29. Tolhurst D.E., and van der Helm T.W.J.S. The treatment of vaginal atresia. Obstet Gynecol Ann 172 (1991) 407
30. Rötth D. Plastic repair of conjunctival defects with fetal membrane. Arch Ophthalmol 23 (1940) 522-525
31. Kim J.C., and Tseng S.C.G. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14 (1995) 473
32. Kim Jc T.S. The effect on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J Ophthalmol 9 (1995) 32-46
33. Shimazaki J., Yang H.Y., and Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104 (1997) 2068-2074
34. Dua H.S., and Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol 83 (1999) 748-752
35. Azuara-Blanco A., Pillai A.T., and Dua H.S. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 83 (1999) 399-402
36. Lee S.H., and Tseng S.C.G. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123 (1997) 303-312
37. Prabhasawat P., and Tesavibul N. Preserved amniotic membrane transplantation for conjunctival surface reconstruction. Cell Tissue Bank 2 (2001) 31-39
38. Prabhasawat P., Kosrirukvongs P., Booranapong W., and Vajaradul Y. Application of preserved human amniotic membrane for corneal surface reconstruction. Cell Tissue Bank 1 (2000) 213-222
39. Rama P., Giannini R., Bruni A., Gatto C., Tiso R., and Ponzin D. Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases. Cell Tissue Bank 2 3 (2001) 155-163
40. Hermans M.H. Clinical experience with glycerol-preserved donor skin treatment in partial thickness burns. Burns 15 (1989) 57
41. Mackie D.P. The Euro Skin Bank: development and application of glycerol-preserved allografts. J Burn Care Rehabil 18 (1997) 7
42. Van Baare J., Buitenwerf J., Hoekstra M.J., and du Pont J.S. Virucidal effect of glycerol as used in donor skin preservation. Burns 20 (1994) 77
43. Van Baare J., Cameron P.U., Vardaxis N., Pagnon J., Reece J., Middlekoop E., and Crowe S.W. Comparison of glycerol preservation with cryopreservation methods on HIV-1 inactivation. J Burn Care Rehabil 19 (1998) 494
44. Simmonds R.J., Holmberg S.D., and Hurwitz R.L. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 326 (1992) 726-732
45. Franck O., Descaragues G., Menguy E., Courville P., Martin J., Brasseur G., and Muraine M. Technique of harvesting and preparation of amniotic membranes. J Fr Ophthalmol 23 (2000) 729
46. Anonymous. From the Centers for Disease Control and Prevention. Update: allograft-associated bacterial infections-United States. JAMA 287 13 (2002) 1642-1644 2002
47. Tomford W.W. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am 77 11 (1995) 1742-1754
48. Kealey G.P. Disease transmission by means of allograft. J Burn Care Rehabil 18 1 Pt 2 (1997) S10-S11
49. EATB. Standards for skin and skin substitutes. In: European Association of Tissue Banks; 2002.
50. EATB. General standards. In: European Association of Tissue Banks; 2002.
51. Guide to safety and quality assurance for organs, tissues and cells. Council of Europe; 2000.
52. von Versen-Höynck F., Syring C., Bachmann S., and Möller D.E. The influence of different preservation and sterilisation steps on the histological properties of amnion allografts-light and scanning electron microscopic studies. Cell Tissue Bank 5 (2004) 45-56
53. DIZG. Procedure manuals. German Institute for Cell and Tissue Replacement; 1996.
54. DIZG. Donor exclusion criteria. German Institute for Cell and Tissue Replacement (2001)
55. Kruse F.E., Joussen A.M., Rohrschneider K., You L., Sinn B., Baumann J., et al. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch Clin Exp Ophthalmol 238 (2000) 68-75
56. von Versen-Höynck F., Hesselbarth U., and Möller D.E. Application of sterilised human amnion for reconstruction of the ocular surface. Cell Tissue Bank 5 (2004) 57-65
57. Tseng S.C.G., Prabhasawat P., and Lee S.H. Amniotic membrane Transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1 24 (1997) 765-774
58. Sterling J.A. Use of amniotic membranes to cover surface defects due to flame burns. Am J Surg 91 (1956) 940-942
59. Sakuragawa N., Yoshikawa H., and Sasaki M. Amniotic tissue transplantation: Clinical and biochemical evaluation for some lysosomal storage disease. Brain Dev 14 (1992) 7
60. DIN Deutsches Institut für Normung e.V. DIN 53380-3 Bestimmung der Gasdurchlässigkeit von Folien in einer Diffusionsmesskammer. Beuth Verlag, Berlin, 7/1998.
61. Schrage N.F., Benz K., Beaujean P., Burchard W.G., and Reim M. A simple empirical calibration of energy dispersive X-ray analysis (EDXA) on the cornea. Scan Microsc 7 3 (1993) 881-888
62. SPSS Inc. Softwarepaket SPSS für Microsoft Windows. v. 9.011. Chicago: SPSS.
63. Bourne G.L. The human amnion and chorion (1962), Lloyd-Luke, London
64. Bourne G.L. The anatomy of the human amnion and chorion. Proc R Soc Med 59 (1966) 1127-1128
65. Kruse F.E., Rohrschneider K., and Völcker H.E. Transplantation von Amnionmembranen zur Rekonstruktion der Augenoberfläche. Operatives Vorgehen. Ophthalmologe 96 (1999) 673
66. Kruse F.E., Rohrschneider K., and Völcker H.E. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106 (1999) 1504
67. Tseng S.C.G., Prabhasawat P., Barton K., Gray T., and Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116 (1998) 431-441
68. Prabhasawat P., Barton K., Burkett G., and Tseng S.C.G. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104 (1997) 974-985
69. Adinolfi M., Akle C.A., and McColl I. Expression of HLA-antigens, b2-microglobulin and enzymes by human amniotic epithelial cells. Nature 295 (1982) 325-330
70. Pruss A., Baumann B., Seibold M., Kao M., Tintelnot K., von Versen R., et al. Validation of the sterilisation procedure of allogeneic avital bone transplants using peracetic acid-ethanol. Biologicals 29 (2001) 59
71. Pruss A., Kao M., Kiesewetter H., von Versen R., Pauli G., and Göbel U.B. Virus safety of avital bone tissue transplants: evaluation of sterilisation steps of spongiosa cuboids using a peracetic acid-methanol mixture. Biologicals 27 (1999) 195
72. Turner T.D. Surgical absorbents. Africa Health 1 4 (1979) 22-24
73. Turner T.D. Hospital usage of absorbent dressings. Pharm J 22 (1979) 421-426
74. Turner T.D. In: Sundell B. (Ed) (1979), Proceedings of Symposium on Wound Healing, Helsinki 75-84
75. Sedlarik K.M. Wundheilung. 2nd ed. (1993), Gustav Fischer, Jena/Stuttgart
76. Wollina U. Synthetische Verbände bei kutanen Wunden. Medwelt 46 (1995) 363-368
77. Eaglestein W.H., Mertz P.M., and Falanga V. Wound dressings: current and future. Prog Clin Biol Res 365 (1991) 257-265
78. Thomas S. Wound management and dressings (1990), Pharmaceutical Press, London
79. Yoshita T., Kobayashi A., Sugiyama K., and Tseng S.C. Oxygen permeability of amniotic membrane and actual tear oxygen tension beneath amniotic membrane patch. Am J Ophthalmol 138 3 (2004) 486-487
80. Fukuda K., Chikama T., Nakamura M., and Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea 18 1 (1999) 73-79
81. Munting E., Wilmart J.F., Wijne A., Hennebert P., and Delloye C. Effect of sterilization on osteoinduction. Acta Orthop Scand 59 1 (1988) 34
82. Komender J., Komender A., Dziendzic A., and Ostrowski K. Radiation-sterilized bone grafts evaluated by electron spin resonance technique and mechanical test. Transplant Proc Suppl 59 1 (1976) 34
83. Approval of the effectiveness of virus inactivation by peracetic acid/ethanol mixtures (1992), Institute of Virology, Humboldt University School of Medicine, Berlin
84. Approval of effectiveness of virus inactivation by peracetic acid/ethanol mixture in a model of human tissue allografts (cancellous bone cubes) (1997), Humboldt University School of Medicine, Institute of Transfusion Medicine and DIZG German Institute for Cell and Tissue Replacement, Berlin
85. Pruss A., Perka C., Degenhardt P., Maronna U., Büttner-Janz K., Paul B., et al. Clinical efficacy and compatibility of allogeneic avital tissue transplants sterilized with peracetic acid/ethanol mixture. Cell Tissue Bank 3 (2002) 235
86. von Versen R., Mönig H., Salai M., and Bettin D. Quality issues in tissue banking: Quality management systems-a review. Cell Tissue Bank 1 (2000) 181-192